Status:
UNKNOWN
Prognostic Interest of Vasorin in Septic Shock
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Collaborating Sponsors:
Centre Hospitalier Abbeville
Conditions:
Sepsis
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In septic shock, the intensity and duration of low blood pressure can lead to a critical reduction in renal tissue perfusion and lead to the onset of more or less severe Acute Kidney Injury (AKI). Vas...
Eligibility Criteria
Inclusion
- Age ≥18 years old.
- Hospitalized in intensive care or medical resuscitation units.
- With a septic shock state defined by 2 mmol/l lactate sepsis, requiring vasopressors to maintain mean blood pressure 65 mmHg (despite adequate vascular filling).
- Whether or not they have developed AKI.
- Patient/family information and collection of non opposition
Exclusion
- Patients with chronic respiratory failure.
- Pregnant women.
- Patients in palliative care.
- Information for the patient/someone close and collection of his opposition
Key Trial Info
Start Date :
July 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06072508
Start Date
July 3 2023
End Date
March 1 2025
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens-Picardie
Amiens, France, 80000